Related Experiment Video

Updated: Jun 22, 2026

A Preclinical Murine Model of Hepatic Metastases
06:51

A Preclinical Murine Model of Hepatic Metastases

Published on: September 27, 2014

Programmed cell death 4 (PDCD4) suppresses metastastic potential of human hepatocellular carcinoma cells

Shuhong Zhang1, Jianfeng Li, Ying Jiang

  • 1Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong University324 Jingwu Weiqi Road, Jinan 250021, PR China. zsh622@yahoo.cn

Journal of Experimental & Clinical Cancer Research : CR
|June 2, 2009
PubMed
Abstract

Insights

Programmed cell death 4 (PDCD4) suppresses hepatocellular carcinoma (HCC) metastasis. Increasing PDCD4 levels in HCC cells reduced proliferation, boosted apoptosis, and inhibited migration and invasion, indicating its potential as an anti-metastasis therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Hepatocellular carcinoma (HCC) is a deadly cancer with high metastasis rates and poor outcomes.
  • Current treatments lack effective strategies to inhibit HCC metastasis.
  • Programmed cell death 4 (PDCD4) acts as a tumor suppressor, but its role in HCC metastasis is underexplored.

Purpose of the Study:

  • To investigate the role of PDCD4 in the metastatic potential of human HCC cells.
  • To determine the correlation between PDCD4 expression and HCC cell metastatic capabilities.

Main Methods:

  • Examined PDCD4 expression in HCC cell lines with varying metastatic potentials (MHCC-97H, MHCC-97L, Hep3B).
  • Constructed and transfected a PDCD4-encoding plasmid into HCC cells with low PDCD4 expression.
  • Assessed the impact of PDCD4 on cell proliferation, apoptosis, metastasis tumor antigen 1 (MTA1) gene expression, and in vitro migration/invasion.

Main Results:

  • PDCD4 expression levels were inversely correlated with HCC cell metastatic potential.
  • PDCD4 gene transfection significantly decreased HCC cell proliferation and increased apoptosis.
  • Transfection with PDCD4 markedly inhibited MTA1 gene expression, HCC cell migration, and Matrigel invasion.

Conclusions:

  • PDCD4 expression is inversely related to the metastatic potential of HCC cells.
  • PDCD4 demonstrates significant potential in suppressing the metastatic capabilities of HCC cells.
  • Targeting PDCD4 may offer a novel therapeutic strategy against HCC metastasis.

More Related Videos

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog08:37

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...